![](/images/general/no_picture/200_user.png)
Thanh Lam
Examiner (ID: 3594, Phone: (571)272-2026 , Office: P/2834 )
Most Active Art Unit | 2834 |
Art Unit(s) | 2834, 2832 |
Total Applications | 2494 |
Issued Applications | 2201 |
Pending Applications | 50 |
Abandoned Applications | 243 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10892913
[patent_doc_number] => 08916525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-23
[patent_title] => 'TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 13/635868
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 15182
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635868
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635868 | TNF-A and TWEAK dual antagonist for the prophylaxis and treatment of autoimmune diseases | Mar 17, 2011 | Issued |
Array
(
[id] => 10169357
[patent_doc_number] => 09200058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Dual antagonist for TNF-α and IL-21 for preventing and treating autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 13/635874
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 13681
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635874
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635874 | Dual antagonist for TNF-α and IL-21 for preventing and treating autoimmune diseases | Mar 17, 2011 | Issued |
Array
(
[id] => 8755255
[patent_doc_number] => 20130089560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/635116
[patent_app_country] => US
[patent_app_date] => 2011-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31875
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635116
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635116 | BONE MORPHOGENETIC PROTEIN RECEPTOR BINDING AGENTS AND METHODS OF THEIR USE | Mar 16, 2011 | Abandoned |
Array
(
[id] => 10887743
[patent_doc_number] => 08911736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Combination therapy for treating breast cancer'
[patent_app_type] => utility
[patent_app_number] => 13/634392
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16166
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/634392 | Combination therapy for treating breast cancer | Mar 7, 2011 | Issued |
Array
(
[id] => 10046024
[patent_doc_number] => 09086418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Methods and compositions for diagnosing ankylosing spondylitis using biomarkers'
[patent_app_type] => utility
[patent_app_number] => 13/034809
[patent_app_country] => US
[patent_app_date] => 2011-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27770
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13034809
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/034809 | Methods and compositions for diagnosing ankylosing spondylitis using biomarkers | Feb 24, 2011 | Issued |
Array
(
[id] => 10586681
[patent_doc_number] => 09308277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage'
[patent_app_type] => utility
[patent_app_number] => 13/029891
[patent_app_country] => US
[patent_app_date] => 2011-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18448
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13029891
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/029891 | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | Feb 16, 2011 | Issued |
Array
(
[id] => 6080086
[patent_doc_number] => 20110142832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/021545
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11275
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142832.pdf
[firstpage_image] =>[orig_patent_app_number] => 13021545
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/021545 | Soluble tumor necrosis factor receptor treatment of medical disorders | Feb 3, 2011 | Issued |
Array
(
[id] => 8648833
[patent_doc_number] => 20130034563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 13/575632
[patent_app_country] => US
[patent_app_date] => 2011-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17088
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575632
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575632 | USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS | Jan 26, 2011 | Abandoned |
Array
(
[id] => 8606094
[patent_doc_number] => 20130011407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/575650
[patent_app_country] => US
[patent_app_date] => 2011-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17078
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575650
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575650 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF OSTEOARTHRITIS, AND METHOD OF PRODUCTION THEREFOR | Jan 26, 2011 | Abandoned |
Array
(
[id] => 8606104
[patent_doc_number] => 20130011416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'INJECTABLE SOLUTION CONTAINING THERAPEUTIC AGENT FOR OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 13/575620
[patent_app_country] => US
[patent_app_date] => 2011-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17291
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575620
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575620 | Injectable solution containing therapeutic agent for osteoarthritis | Jan 26, 2011 | Issued |
Array
(
[id] => 6001733
[patent_doc_number] => 20110117584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Detection of Chronic Kidney Disease Patients or Coronary Artery Disease Using Bone Morphogenic Protein-4'
[patent_app_type] => utility
[patent_app_number] => 13/009428
[patent_app_country] => US
[patent_app_date] => 2011-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3465
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117584.pdf
[firstpage_image] =>[orig_patent_app_number] => 13009428
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/009428 | Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4 | Jan 18, 2011 | Issued |
Array
(
[id] => 5958519
[patent_doc_number] => 20110182906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'FULLY HUMAN ANTIBODY TO HUMAN TNF-ALPHA, MOLECULAR EVOLUTION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/008015
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6354
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182906.pdf
[firstpage_image] =>[orig_patent_app_number] => 13008015
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008015 | Fully human antibody to human TNFα, molecular evolution and use thereof | Jan 17, 2011 | Issued |
Array
(
[id] => 6187841
[patent_doc_number] => 20110171228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins'
[patent_app_type] => utility
[patent_app_number] => 13/008566
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28831
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171228.pdf
[firstpage_image] =>[orig_patent_app_number] => 13008566
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008566 | Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins | Jan 17, 2011 | Abandoned |
Array
(
[id] => 6187845
[patent_doc_number] => 20110171231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'ANTI-PlGF ANTIBODIES AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/005067
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35939
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171231.pdf
[firstpage_image] =>[orig_patent_app_number] => 13005067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005067 | ANTI-PlGF ANTIBODIES AND METHODS USING SAME | Jan 11, 2011 | Abandoned |
Array
(
[id] => 5943493
[patent_doc_number] => 20110104113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE'
[patent_app_type] => utility
[patent_app_number] => 12/987016
[patent_app_country] => US
[patent_app_date] => 2011-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9897
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104113.pdf
[firstpage_image] =>[orig_patent_app_number] => 12987016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/987016 | Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device | Jan 6, 2011 | Issued |
Array
(
[id] => 6111511
[patent_doc_number] => 20110189769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/975160
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6071
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189769.pdf
[firstpage_image] =>[orig_patent_app_number] => 12975160
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/975160 | METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS | Dec 20, 2010 | Abandoned |
Array
(
[id] => 9762293
[patent_doc_number] => 08846616
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-09-30
[patent_title] => 'Alpha-melanocyte stimulating hormone as topical anti-inflammatory agent for the treatment of allergic contact dermatitis and eczema'
[patent_app_type] => utility
[patent_app_number] => 12/942369
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7830
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12942369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/942369 | Alpha-melanocyte stimulating hormone as topical anti-inflammatory agent for the treatment of allergic contact dermatitis and eczema | Nov 8, 2010 | Issued |
Array
(
[id] => 8796657
[patent_doc_number] => 08435525
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-05-07
[patent_title] => 'FGF modulation of in vivo antibody production and humoral immunity'
[patent_app_type] => utility
[patent_app_number] => 12/941070
[patent_app_country] => US
[patent_app_date] => 2010-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 10477
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12941070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941070 | FGF modulation of in vivo antibody production and humoral immunity | Nov 6, 2010 | Issued |
Array
(
[id] => 6142186
[patent_doc_number] => 20110129469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'METHODS FOR TREATING FATTY LIVER DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/939084
[patent_app_country] => US
[patent_app_date] => 2010-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19070
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129469.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939084
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939084 | METHODS FOR TREATING FATTY LIVER DISEASE | Nov 2, 2010 | Abandoned |
Array
(
[id] => 6084467
[patent_doc_number] => 20110144205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure'
[patent_app_type] => utility
[patent_app_number] => 12/908163
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10096
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908163
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908163 | Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure | Oct 19, 2010 | Abandoned |